癌症的聯合治療
- 专利权人:
- 发明人:
- 申请号:
- HK18102198.6
- 公开号:
- HK1242716A
- 申请日:
- 2018.02.12
- 申请国别(地区):
- HK
- 年份:
- 2018
- 代理人:
- 摘要:
- Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- SPECIFIC POINT INHIBITORS
- POLYTHERAPIE CONTRE LE CANCER
- Combination therapy for cancer
- Combination therapy with melestinib and anti-PD-L1 or anti-PD-1 inhibitor for use in the treatment of cancer
- COMBINATION THERAPY WITH MERESTINIB AND ANTI-PD-L1 OR ANTI-PD-1 INHIBITORS FOR USE IN THE TREATMENT OF CANCER